Australian Government - Department of Health and Ageing

Medical Services Advisory Committee (MSAC)

Reference 16

Positron emission tomography (PET) for non-small-cell lung cancer and solitary pulmonary nodules

Positron emission tomography (PET) for non-small-cell lung cancer and solitary pulmonary nodules

Application No.

16

Application NamePositron emission tomography (PET) for non-small-cell lung cancer and solitary pulmonary nodules
Advisory PanelAssociate Professor Richard King
(Chair and MSAC member)
Professor Brendon Kearney
(MSAC member)
Professor John Simes
(MSAC member)
Dr Michael Kitchener
(MSAC member)
Dr Ray Kirk
(MSAC member)
Dr Barry Chatterton
(co-opted member)
Associate Professor Michael Fulham
(Association of Physicians in Nuclear Medicine nominee)
Associate Professor Peter Holmes
(co-opted member)
Dr Michael Millward
(Royal Australian College of Surgeons nominee)
Associate Professor Anrdew Scott
(Australian and New Zealand Association of Physicians in Nuclear Medicine nominee)
Date Received by MSAC SecretariatJuly 2002
Stage 1 - EligibilityEligible
Stage 2 - AssessmentCompleted
Stage 3 - Formulation of Advice to the MinisterThis assessment was considered by the MSAC at the 19 November 2003 meeting.

The MSAC agreed that public funding for PET for solitary pulmonary nodules (SPN) and non-small-cell lung cancer (NSCLC) should be supported.
Stage 4 - DecisionEndorsed by the Minister for Health and Ageing 2 March 2005
Stage 5 - Implementation

Page currency, Latest update: 30 March, 2009